The effects of cognitive-behavioral therapy (CBT) on central dopamine (DA), noradrenaline (NE) and serotonin (5-HT) secretion were studied in a group of 50 female inpatients, of which 14 suffered from anorexia nervosa restricted type (AN-R), 14 from anorexia nervosa bingeing—purging type (AN-BP), and 22 from bulimia nervosa (BN). The aim of the study was to see whether or not CBT modifies the secretion of central DA (blood homovanillic acid = HVA), NE (blood 3-methoxy-4-hydroxy-phenylglycol = MHPG) and the 5-HT transporter (as evaluated by the platelet paroxetine binding = [3H]-Par-binding), if the physical and psychological effects of CBT correlate with changes of the neurotransmitter secretion; and if the biological effects of CBT are linked to specific psychopathological aspect of the disorders. The treatment lasted 20 weeks. Body-mass Index, bingeing and purging, specific AN—BN psychopathological (EDE 12-OD), depression (Beck Inventory), anxiety (STAY Form-Y-1), impulsiveness (Barratt Impulsiveness Scale), self-esteem (Rosenberg Self-Biochemical Scale) and temperament (Temperament and Character Inventory, Cloninger Scale) were assessed at baseline and at the end of the treatment. CBTsignificantly improved the psychophysical aspects of the diseases. HVA and MHPG concentrations did not change. The [3H]-Par-binding parameters, the maximum binding capacity (Bmax) and dissociation constant (Kd) values did not change in either AN-R or AN-BP patients, while the [3H]-Par Bmax (and not the Kd) increased significantly in BN patients. Correlations emerged between basal and final [3H]-Par Bmax values and psychopathological scores, but not between CBT-induced differences between basal and final values. Our data suggest that only in BN CBT may act through changes in 5-HT system function.

F. Brambilla, R. Dalle Grave, S. Calugi, G. Marchesini Reggiani, S. Baroni, D. Marazziti (2010). Effects of cognitive-behavioral therapy on eating disorders: neurotransmitter secretory response to treatment. PSYCHONEUROENDOCRINOLOGY, 35(5), 729-737 [10.1016/j.psyneuen.2009.10.014].

Effects of cognitive-behavioral therapy on eating disorders: neurotransmitter secretory response to treatment

CALUGI, SIMONA;MARCHESINI REGGIANI, GIULIO;
2010

Abstract

The effects of cognitive-behavioral therapy (CBT) on central dopamine (DA), noradrenaline (NE) and serotonin (5-HT) secretion were studied in a group of 50 female inpatients, of which 14 suffered from anorexia nervosa restricted type (AN-R), 14 from anorexia nervosa bingeing—purging type (AN-BP), and 22 from bulimia nervosa (BN). The aim of the study was to see whether or not CBT modifies the secretion of central DA (blood homovanillic acid = HVA), NE (blood 3-methoxy-4-hydroxy-phenylglycol = MHPG) and the 5-HT transporter (as evaluated by the platelet paroxetine binding = [3H]-Par-binding), if the physical and psychological effects of CBT correlate with changes of the neurotransmitter secretion; and if the biological effects of CBT are linked to specific psychopathological aspect of the disorders. The treatment lasted 20 weeks. Body-mass Index, bingeing and purging, specific AN—BN psychopathological (EDE 12-OD), depression (Beck Inventory), anxiety (STAY Form-Y-1), impulsiveness (Barratt Impulsiveness Scale), self-esteem (Rosenberg Self-Biochemical Scale) and temperament (Temperament and Character Inventory, Cloninger Scale) were assessed at baseline and at the end of the treatment. CBTsignificantly improved the psychophysical aspects of the diseases. HVA and MHPG concentrations did not change. The [3H]-Par-binding parameters, the maximum binding capacity (Bmax) and dissociation constant (Kd) values did not change in either AN-R or AN-BP patients, while the [3H]-Par Bmax (and not the Kd) increased significantly in BN patients. Correlations emerged between basal and final [3H]-Par Bmax values and psychopathological scores, but not between CBT-induced differences between basal and final values. Our data suggest that only in BN CBT may act through changes in 5-HT system function.
2010
F. Brambilla, R. Dalle Grave, S. Calugi, G. Marchesini Reggiani, S. Baroni, D. Marazziti (2010). Effects of cognitive-behavioral therapy on eating disorders: neurotransmitter secretory response to treatment. PSYCHONEUROENDOCRINOLOGY, 35(5), 729-737 [10.1016/j.psyneuen.2009.10.014].
F. Brambilla; R. Dalle Grave; S. Calugi; G. Marchesini Reggiani; S. Baroni; D. Marazziti
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/89246
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact